No Detail Found!

Clinical efficacy of sufentanil combined with dexmedetomidine in patient-controlled subcutaneous analgesia for advanced cancer pain

Author(s)
Fangfang Xiao Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Baochang Du Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Hongyan Zhang Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Jie Zhang Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Baoxin Wang Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Qian Guo Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Xiuheng Qi Department of Oncology, Hebei PetroChina Central Hospital,Langfang, Hebei,China
Abstract
To evaluate the efficacy of sufentanil combined with dexmedetomidine in patient-controlled subcutaneous analgesia (PSCA) for advanced cancer pain, 62 patients with advanced cancer pain treated in Department of Oncology of Hebei PetroChina Central Hospital from January 2017 to May 2020 were recruited and assigned via the random number table method to either the control group or the observation group. The control group (group A) received PSCA with sufentanil and the observation group was divided into group B1 receiving PSCA with sufentanil and dexmedetomidine (20:1) and group B2 given PSCA with sufentanil and dexmedetomidine (10:1). The numeric rating scale (NRS) scores of patients in the three groups decreased significantly after medication (P0.05). Significantly higher Ramsay sedation scores were observed in groups B1 and B2 than in group A after drug administration (P0.05). The incidence of constipation, nausea and vomiting in group B1 and group B2 was significantly lower than that in group A. PSCA with sufentanil and dexmedetomidine is effective in patients with cancer pain.
Publication Details
Page(s) 947-951
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 36, Issue: S3, Year: 2023

Request the full text from PASTIC

Keywords
Dexmedetomidine, cancer pain, Patient-controlled subcutaneous analgesia, Sufentanil, advanced cancer
References
Amorim MA,Govêia CS,Magalhaes E,Ladeira LC,Moreira LG,Miranda DB .2017 .Effect of dexmedetomidine in children undergoing general anesthesia with sevoflurane: A meta-analysis. Braz. J. Anesthesiol., 67(2) : 193-198.
Arain SR,Ruehlow RM,Uhrich TD,Ebert TJ .2004 .The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg, 98(1) : 153-158.
Barends CR,Absalom A,van Minnen B,Vissink A,Visser A .2017 .Dexmedetomidine versus Midazolam in Procedural Sedation. A Systematic Review of Efficacy and Safety. PLoS One, 12(1) : e0169525.
Bhatnagar S and Gupta M .2015 .Evidence-based clinical practice guidelines for interventional pain management in cancer pain. Indian J. Palliat Care, 21(2) : 137-147.
Gursoy S,Ozdemir E,Bagcivan I,Altun A,Durmus N A .2011 .Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats. Ups J. Med. Sci., 116(4) : 238-246.
Mohamed AA,Fares KM,Mohamed SA .2012 .Efficacy of intrathecally administered dexmedetomidine versus dexmedetomidine with fentanyl in patients undergoing major abdominal cancer surgery. Pain Physician, 15(4) : 339-348.
Qin M,Chen K,Liu T,Shen X .2017 .Dexmedetomidine in combination with sufentanil for postoperative analgesia after partial laryngectomy. BMC Anesthesiol, 17(1) : 66.
Ramsay MA,Newman KB,Leeper B,Hamman BL,Hebeler RF,Henry AC,Kourlis H,Wood RE,Stecher JA,Hein HA .2014 .Dexmedetomidine infusion for analgesia up to 48 hours after lung surgery performed by lateral thoracotomy. Proc. (Bayl Univ Med Cent), 27(1) : 3-10.
Shi C,Jin J,Qiao L,Li T,Ma J .2019 .Effect of perioperative administration of dexmedetomidine on delirium after cardiac surgery in elderly patients: A double-blinded, multi-center, randomized study. Clin. Interv. Aging, 14 : 571-575.
Pak. J. Pharm. Sci. ,Sivaramakrishnan G .2019 .Drugs for preventing post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: Network meta-analysis of randomized clinical trials and trial sequential analysis. Int. J. Surg., 69(Special) : 1-12.
Tang C,Hu Y,Zhang Z,Wei Z,Wang H,Geng Q,Shi S,Wang S,Wang J,Chai X .2020 .Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery. Biosci. Rep, 40(5) : BSR20193410.
Tisotti T,Valverde A,Hopkins A,O'Sullivan ML,Hanna B,Arroyo L .2021 .Use of intravenous lidocaine to treat dexmedetomidine-induced bradycardia in sedated and anesthetized dogs. Vet, 48(2) : 174-186.
Wang W,Feng L,Bai F,Zhang Z,Zhao Y,Ren C Y .2016 .The safety and efficacy of dexmedetomidine vs. sufentanil in monitored anesthesia care during burrhole surgery for chronic subdural hematoma: A retrospective clinical trial. Front Pharmacol, 7 : 410.
Weerink MAS,Struys MMRF,Hannivoort LN,Barends CRM,Absalom AR,Colin P .2017 .Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin. Pharmacokinet, 56(8) : 893-913.
Zhao L,Li Y .2020 .Application of dexmedetomidine combined with sufentanil in colon cancer resection and its effect on immune and coagulation function of patients. Oncol. Lett., 20(2) : 1288-1294.
Zhou Y,Huang JX,Lu XH,Zhang YF .2015 .Patient-controlled intravenous analgesia for non-small cell lung cancer patient after thoracotomy. J. Cancer Res. Ther., 11(Suppl 1) : C128-C130.
0

Citations

0

Downloads

94

Views